Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib maintenance in Asian women with ovarian cancer
NCT01227928Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2010
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of pazopanib in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal carcinoma (PPC), sponsored by GSK. Started Sep 2010; status: completed.
02
Drugs
pazopanib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT01227928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01227928.